Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Double-blind, Multicenter Study to Investigate the Safety and Duration of Effect of Different NT 201 Dose Groups Following the Treatment of Glabellar Frown Lines
Conditions
Interventions
NT 201
Locations
9
United States
Clinical Testing of Beverly Hills, Merz Investigational Site #0010395
Encino, California, United States
Medical Associates Inc., Merz Investigational Site #0010435
Newport Beach, California, United States
Cosmetic Laser Dermatology, Merz Investigational Site #0010321
San Diego, California, United States
The Maas Clinics, Merz Investigational Site #0010338
San Francisco, California, United States
Tennessee Clinical Research Center, Merz Investigational Site #0010097
Nashville, Tennessee, United States
Privatpraxis für Dermatologie und Ästhetische Medizin, Merz Investigational Site #0490306
Berlin, Germany
Start Date
January 23, 2019
Primary Completion Date
September 10, 2020
Completion Date
October 8, 2020
Last Updated
November 15, 2023
Lead Sponsor
Merz Aesthetics GmbH
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions